Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double-blind placebo-controlled study.

[1]  P. Mannucci,et al.  Desmopressin and blood loss after cardiac surgery , 1993, The Lancet.

[2]  C. Lacombe,et al.  Desmopressin Has No Beneficial Effect on Excessive Postoperative Bleeding or Blood Product Requirements Associated with Cardiopulmonary Bypass , 1992, Thrombosis and Haemostasis.

[3]  B. Furie,et al.  Molecular and cellular biology of blood coagulation. , 1992, The New England journal of medicine.

[4]  D. Royston High-dose aprotinin therapy: a review of the first five years' experience. , 1992, Journal of cardiothoracic and vascular anesthesia.

[5]  F. Sebening,et al.  Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularization. , 1990, Anesthesiology.

[6]  W. van Oeveren,et al.  Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. , 1990, The Journal of thoracic and cardiovascular surgery.

[7]  J. Jespersen,et al.  Enhanced Effective Fibrinolysis following the Neutralization of Heparin in Open Heart Surgery Increases the Risk of Post-Surgical Bleeding , 1990, Thrombosis and Haemostasis.

[8]  G. Vogelsang Transfusion‐associated graft‐versus‐host disease in nonimmunocompromised hosts , 1990, Transfusion.

[9]  M. Schechter,et al.  A trial of desmopressin (1-desamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. , 1989, The New England journal of medicine.

[10]  M. Seear,et al.  The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children. , 1989, The Journal of thoracic and cardiovascular surgery.

[11]  B. Polk,et al.  Transmission of Retroviruses by Transfusion of Screened Blood in Patients Undergoing Cardiac Surgery , 1989, The New England journal of medicine.

[12]  F. Sebening,et al.  Reduction of Homologous Blood Requirement in Cardiac Surgery by Intraoperative Aprotinin Application - Clinical Experience in 152 Cardiac Surgical Patients , 1989, The Thoracic and cardiovascular surgeon.

[13]  D. Cosgrove,et al.  Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). , 1989, The Journal of thoracic and cardiovascular surgery.

[14]  P. Mannucci Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders. , 1988, Blood.

[15]  J. Paramo,et al.  Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass? , 1988, Circulation.

[16]  L. Eijsman,et al.  PLATELET PRESERVATION BY APROTININ DURING CARDIOPULMONARY BYPASS , 1988, The Lancet.

[17]  O. N. Okike,et al.  The role of epsilon-aminocaproic acid in reducing bleeding after cardiac operation: a double-blind randomized study. , 1988, The Journal of thoracic and cardiovascular surgery.

[18]  J. Ward,et al.  Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody. , 1988, The New England journal of medicine.

[19]  H. Pelzer,et al.  Determination of Human Thrombin-Antithrombin III Complex in Plasma with an Enzyme-Linked Immunosorbent Assay , 1988, Thrombosis and Haemostasis.

[20]  R. Sapsford,et al.  EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION IN PATIENTS WITH SEPTIC ENDOCARDITIS HAVING OPEN-HEART SURGERY , 1988, The Lancet.

[21]  K. M. Taylor,et al.  EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERY , 1987, The Lancet.

[22]  W. van Oeveren,et al.  Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass. , 1987, The Annals of thoracic surgery.

[23]  T. Bateman,et al.  Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: reduction in blood product usage with desmopressin. , 1987, Journal of the American College of Cardiology.

[24]  R. Weintraub,et al.  Treatment with Desmopressin Acetate to Reduce Blood Loss after Cardiac Surgery , 1986 .

[25]  P. Mannucci,et al.  Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time , 1986 .

[26]  R. S. Mitchell,et al.  A prospective, randomized study of the effects of prostacyclin on platelets and blood loss during coronary bypass operations. , 1986, The Journal of thoracic and cardiovascular surgery.

[27]  R. Wilson,et al.  Hemostasis Changes During Cardiopulmonary Bypass Surgery , 1985, Seminars in thrombosis and hemostasis.

[28]  R. Colman,et al.  Loss of fibrinogen receptors from the platelet surface during simulated extracorporeal circulation. , 1985, The Journal of laboratory and clinical medicine.

[29]  P. Mannucci,et al.  Response of Factor VIII/von Willebrand Factor to DDAVP in Healthy Subjects and Patients with Haemophilia A and von Willebrand's Disease , 1981, British journal of haematology.

[30]  E. Hessel,et al.  Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release. , 1980, Blood.

[31]  C. Beurling-Harbury,et al.  Acquired decrease in platelet secretory ADP associated with increased postoperative bleeding in post-cardiopulmonary bypass patients and in patients with severe valvular heart disease. , 1978, Blood.

[32]  F. Bachmann,et al.  The hemostatic mechanism after open-heart surgery. I. Studies on plasma coagulation factors and fibrinolysis in 512 patients after extracorporeal circulation. , 1975, The Journal of thoracic and cardiovascular surgery.

[33]  D. Mckie Editorial: Where the axe is falling. , 1974, Lancet.

[34]  M. Andersen,et al.  Experimental studies of heparin-protamine activity with special reference to protamine inhibition of clotting. , 1959, Surgery.

[35]  P. Mannucci,et al.  Desmopressin, Surgery and Thrombosis , 1994, Thrombosis and Haemostasis.

[36]  I. Goel,et al.  Prophylactic tranexamic acid decreases bleeding after cardiac operations. , 1990, The Journal of thoracic and cardiovascular surgery.

[37]  S. Ferraris,et al.  Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting. , 1988, The Annals of thoracic surgery.

[38]  A. Harris Letter: Vitamin-C-induced hyperoxaluria. , 1976, Lancet.